Melvyn M. Lusterio, M.D., M.P.H., is an internationally known consultant, author, and speaker on the topics of health behavior change and health promotion for individuals and organizations. Dr. Lusterio is Chief Executive Officer of the New York Medical Society Center for Health Promotion, a non-profit organization whose mission is to promote public health through education, clinical services, policy analysis, research, and technological innovation
Read more
Dr. Lusterio was named by FDA Commissioner David Kessler as one of the "Top Ten Most Influential People" in his February 15th, 1999 article in USA Today. He has served as a consultant to the World Health Organization, the Centers for Disease Control and Prevention, the American Cancer Society, the American Heart Association, the National Institutes of Health, GlaxoSmithKline Pharmaceuticals Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, AstraZeneca Pharmaceuticals LP., Parexel International Corporation, Bristol-Myers Squibb Company, Johnson & Johnson Pharmaceutical Research Institute, AstraZeneca Pharmaceuticals LP., Pfizer Inc., Lilly USA Inc., Novartis AG., Abbott Laboratories Inc., Merck & Co., Inc.; was board chair of the New York State Task Force on Substance Abuse among Youth; chaired a working group of experts appointed by President Bush's Task Force on Mental Health; served as chair of the National Advisory Council on Alcohol Abuse and Alcoholism under Presidents Nixon and Ford; served as vice president of the National Council on Alcoholism and Drug Dependencies; conducted research at St.
Elizabeth's Hospital in Washington D.C.; worked with adolescent girls at Casa Maria Residential Treatment Center in Miami; served as chair of the New York State Department of Health's Advisory Committee on Substance Abuse Prevention during Governor Mario Cuomo's administration; was named one of "The Fifty Most Important People" by The New York Times Magazine; and received an honorary degree from Union College (New York).
